BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

27.37B

Market cap27.37B

Price-Earnings ratio

-43.26

Price-Earnings ratio-43.26

Dividend yield

—

Dividend yield—

Average volume

1.13M

Average volume1.13M

High today

$116.97

High today$116.97

Low today

$113.16

Low today$113.16

Open price

$115.96

Open price$115.96

Volume

872.74K

Volume872.74K

52 Week high

$124.98

52 Week high$124.98

52 Week low

$81.20

52 Week low$81.20

BNTX News

TipRanks 1d

BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer

Bristol-Myers Squibb Company (BMY), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Study Overview BioNTech and Bristol-...

Simply Wall St 2d

BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift

BioNTech has started a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer. The company is moving fur...

TipRanks 4d

BioNTech Adds Chief People Officer to Management Board to Support Oncology Growth Strategy

BioNTech SE ( (BNTX) ) has shared an announcement. On January 28, 2026, BioNTech SE announced that its Supervisory Board has appointed seasoned HR executive Ky...

Analyst ratings

82%

of 22 ratings

Buy

81.8%

Hold

18.2%

Sell

More BNTX News

TipRanks 5d

BioNTech’s New Phase III Prostate Cancer Trial Adds Long-Term Upside Potential for BNTX

Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium BioNTech Targets Advanced Prostate Cancer...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.